Published in J Hepatol on March 01, 1997
Electrostatic modifications of the human leukocyte antigen-DR P9 peptide-binding pocket and susceptibility to primary sclerosing cholangitis. Hepatology (2011) 1.51
The immunobiology of primary sclerosing cholangitis. Semin Immunopathol (2009) 1.15
Etiopathogenesis of primary sclerosing cholangitis. World J Gastroenterol (2008) 0.96
Autoantibodies in primary sclerosing cholangitis. World J Gastroenterol (2008) 0.81
Analytical review of diagnosis and treatment strategies for dominant bile duct strictures in patients with primary sclerosing cholangitis. HPB (Oxford) (2011) 0.81
Atopy in children of families with an anthroposophic lifestyle. Lancet (1999) 3.41
Periampullary adenomas and adenocarcinomas in familial adenomatous polyposis: cumulative risks and APC gene mutations. Gastroenterology (2001) 2.85
Natural history and prognostic factors in 305 Swedish patients with primary sclerosing cholangitis. Gut (1996) 2.40
Smoking increases peptidylarginine deiminase 2 enzyme expression in human lungs and increases citrullination in BAL cells. Ann Rheum Dis (2008) 2.27
Early BCG vaccination and development of atopy. Lancet (1997) 2.23
Association of rheumatoid arthritis with a dominant DR1/Dw4/Dw14 sequence motif, but not with T cell receptor beta chain gene alleles or haplotypes. Arthritis Rheum (1991) 2.20
HLA-DR15 is associated with lower age at onset in multiple sclerosis. Ann Neurol (2000) 2.05
Evidence in support of a self-perpetuating HLA-DR-dependent delayed-type cell reaction in rheumatoid arthritis. Proc Natl Acad Sci U S A (1982) 1.99
Exosomes with major histocompatibility complex class II and co-stimulatory molecules are present in human BAL fluid. Eur Respir J (2003) 1.97
CD44 is necessary for optimal contact allergic responses but is not required for normal leukocyte extravasation. J Exp Med (1993) 1.91
Multiple sclerosis: a modifying influence of HLA class I genes in an HLA class II associated autoimmune disease. Tissue Antigens (2000) 1.82
Rectal cancer risk in patients treated for familial adenomatous polyposis. The Leeds Castle Polyposis Group. Br J Surg (1992) 1.81
Association of Campylobacter pylori with induced expression of class II transplantation antigens on gastric epithelial cells. Infect Immun (1989) 1.77
Increased risk for cancer following sarcoidosis. Am J Respir Crit Care Med (1999) 1.76
In situ identification of T lymphocyte subsets and HLA-DR expressing cells in the human skin tuberculin reaction. Clin Exp Immunol (1982) 1.71
T cell receptor V-segment frequencies in peripheral blood T cells correlate with human leukocyte antigen type. J Exp Med (1991) 1.69
Increased frequency of autoimmune diseases in patients with primary sclerosing cholangitis. Am J Gastroenterol (2000) 1.67
Intracellular reservoir of Streptococcus pyogenes in vivo: a possible explanation for recurrent pharyngotonsillitis. Laryngoscope (1997) 1.67
HLA-DR and HLA-DQ are not markers for rapid disease progression in primary sclerosing cholangitis. Gastroenterology (1995) 1.66
Liver investigation in 149 asymptomatic patients with moderately elevated activities of serum aminotransferases. Scand J Gastroenterol (1986) 1.63
Targeting of human dendritic cells by autologous NK cells. J Immunol (1999) 1.62
Characterisation of natural killer cells and CD56+ T-cells in sarcoidosis patients. Eur Respir J (2005) 1.62
Oral budesonide versus prednisolone in patients with active extensive and left-sided ulcerative colitis. Gastroenterology (1996) 1.58
Lung and blood T-cell receptor repertoire in extrinsic allergic alveolitis. Eur Respir J (1997) 1.54
Risk of tuberculosis in a large sample of patients with coeliac disease--a nationwide cohort study. Aliment Pharmacol Ther (2011) 1.54
Germ-line polymorphism of TCR genes and disease susceptibility--fact or hypothesis? Immunol Today (1992) 1.53
Changes in immune regulation in response to examination stress in atopic and healthy individuals. Clin Exp Allergy (2006) 1.52
High dose ursodeoxycholic acid in primary sclerosing cholangitis does not prevent colorectal neoplasia. Aliment Pharmacol Ther (2012) 1.49
Allergic diseases and atopic sensitization in children related to farming and anthroposophic lifestyle--the PARSIFAL study. Allergy (2006) 1.49
Effectiveness of occlusive bedding in the treatment of atopic dermatitis--a placebo-controlled trial of 12 months' duration. Allergy (2001) 1.46
Prevalence of a haemochromatosis among men with clinically significant bradyarrhythmias. Eur Heart J (1989) 1.45
Treatment with gamma-interferon triggers the onset of collagen arthritis in mice. Arthritis Rheum (1988) 1.44
T-cell receptor alpha chain germline gene polymorphisms in multiple sclerosis. Neurology (1992) 1.43
Detection and characterization of focal liver lesions with contrast-enhanced ultrasonography in patients with hepatitis C-induced liver cirrhosis. Acta Radiol (2008) 1.42
Pityrosporum orbiculare and atopic eczema. Allergy (1993) 1.42
Coeliac disease and risk of tuberculosis: a population based cohort study. Thorax (2006) 1.41
Similar T helper Th2-like cytokine mRNA expression in vernal keratoconjunctivitis regardless of atopic constitution. Allergy (2002) 1.40
Lack of antagonism to Ni2+ and Co2+ contact allergy from other essential divalent metal ions. Contact Dermatitis (1998) 1.38
Liver damage from flucloxacillin, cloxacillin and dicloxacillin. J Hepatol (1992) 1.38
Antibacterial components in bronchoalveolar lavage fluid from healthy individuals and sarcoidosis patients. Am J Respir Crit Care Med (1999) 1.37
Restricted V alpha 2.3 gene usage by CD4+ T lymphocytes in bronchoalveolar lavage fluid from sarcoidosis patients correlates with HLA-DR3. Eur J Immunol (1992) 1.35
HLA class II haplotypes in primary sclerosing cholangitis patients from five European populations. Tissue Antigens (1999) 1.35
PDGF-mediated chemoattraction of hepatic stellate cells by bile duct segments in cholestatic liver injury. Lab Invest (2000) 1.32
Identification of the HLA-DRB1*04, -DRB1*07, and -DRB1*09 alleles by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours. Hum Immunol (1992) 1.31
Immunoglobulin M and G antibody responses to Plasmodium falciparum glutamate-rich protein: correlation with clinical immunity in Gambian children. Infect Immun (1993) 1.31
Phenotypic characterization in situ of inflammatory cells in allergic and irritant contact dermatitis in man. Clin Exp Immunol (1984) 1.29
The multiple sclerosis- and narcolepsy-associated HLA class II haplotype includes the DRB5*0101 allele. Tissue Antigens (1995) 1.29
Alpha 4 integrin directs virus-activated CD8+ T cells to sites of infection. J Immunol (1995) 1.28
HLA-DR predicts the prognosis in Scandinavian patients with pulmonary sarcoidosis. Am J Respir Crit Care Med (1997) 1.27
T and B cell responses of Plasmodium falciparum malaria-immune individuals to synthetic peptides corresponding to sequences in different regions of the P. falciparum antigen Pf155/RESA. J Immunol (1989) 1.21
An increased number of gamma/delta T-cells and gastric epithelial cell expression of the groEL stress-protein homologue in Helicobacter pylori-associated chronic gastritis of the antrum. Am J Gastroenterol (1991) 1.20
Lymphocytic choriomeningitis virus infection is associated with long-standing perturbation of LFA-1 expression on CD8+ T cells. Scand J Immunol (1995) 1.19
Analysis of intracellular cytokines in CD4+ and CD8+ lung and blood T cells in sarcoidosis. Am J Respir Crit Care Med (2001) 1.19
Exosomes - nanovesicles with possible roles in allergic inflammation. Allergy (2008) 1.19
Is the sanctuary where Helicobacter pylori avoids antibacterial treatment intracellular? Am J Clin Pathol (1997) 1.15
Human keratinocytes express HLA-DR antigens in the tuberculin reaction. Scand J Immunol (1984) 1.15
Liver disease in ulcerative colitis: an epidemiological and follow up study in the county of Stockholm. Gut (1994) 1.15
Road tunnel air pollution induces bronchoalveolar inflammation in healthy subjects. Eur Respir J (2007) 1.13
Detection of Mala f and Mala s allergen sequences within the genus Malassezia. Med Mycol (2003) 1.13
Bacterial and fungal agents in house dust and wheeze in children: the PARSIFAL study. Clin Exp Allergy (2005) 1.13
Highly activated T-cell receptor AV2S3(+) CD4(+) lung T-cell expansions in pulmonary sarcoidosis. Am J Respir Crit Care Med (2001) 1.12
Different expression of HLA-DR and ICAM-1 in livers from patients with biliary atresia and Byler's disease. J Hepatol (1997) 1.12
Genetic regulation of human anti-malarial antibodies in twins. Proc Natl Acad Sci U S A (1992) 1.11
Selective cloning of allergens from the skin colonizing yeast Malassezia furfur by phage surface display technology. J Invest Dermatol (1999) 1.11
T-cell receptor variable region gene usage by CD4+ and CD8+ T cells in bronchoalveolar lavage fluid and peripheral blood of sarcoidosis patients. Proc Natl Acad Sci U S A (1994) 1.11
Increased expression of platelet-derived growth factor type B receptors in the skin of patients with systemic sclerosis. Arthritis Rheum (1990) 1.11
Inoculation of barrier-born pigs with Helicobacter pylori: a useful animal model for gastritis type B. Infect Immun (1990) 1.11
Analysis of regulatory T cell associated forkhead box P3 expression in the lungs of patients with sarcoidosis. Clin Exp Immunol (2008) 1.10
A population study on irritable bowel syndrome and mental health. Scand J Gastroenterol (2000) 1.10
Increased interleukin-13 mRNA expression in bronchoalveolar lavage cells of atopic patients with mild asthma after repeated low-dose allergen provocations. Respir Med (2000) 1.10
Class II transplantation antigens: distribution in tissues and involvement in disease. Scand J Immunol (1985) 1.08
Bronchoalveolar lavage fluid exosomes contribute to cytokine and leukotriene production in allergic asthma. Allergy (2012) 1.08
Morphological findings in the liver of children with cystic fibrosis: a light and electron microscopical study. Hepatology (1986) 1.08
Growth-regulatory effects of sensory neuropeptides, epidermal growth factor, insulin, and somatostatin on the non-transformed intestinal epithelial cell line IEC-6 and the colon cancer cell line HT 29. Scand J Gastroenterol (1993) 1.07
Present progress towards the laboratory colonization of African Simuliidae (Diptera). Tropenmed Parasitol (1975) 1.07
Liver histology and follow up of 68 patients with ulcerative colitis and normal liver function tests. Gut (1990) 1.06
Macrophages, but not dendritic cells, present collagen to T cells. Eur J Immunol (1995) 1.05
Virtual reality colonoscopy simulation: a compulsory practice for the future colonoscopist? Endoscopy (2005) 1.05
HFE mutations in patients with hereditary haemochromatosis in Sweden. J Intern Med (1998) 1.05
An immunogenetic heterogeneity in multiple sclerosis. J Neurol Neurosurg Psychiatry (1992) 1.04
Lung restricted T cell receptor AV2S3+ CD4+ T cell expansions in sarcoidosis patients with a shared HLA-DRbeta chain conformation. Thorax (2002) 1.02
Duodenal adenomatosis in familial adenomatous polyposis. DAF Project Group. Int J Colorectal Dis (1995) 1.02
Lifestyle factors and sensitization in children - the ALADDIN birth cohort. Allergy (2011) 1.02
Phenotypic analysis of lymphocytes and monocytes/macrophages in peripheral blood and bronchoalveolar lavage fluid from patients with pulmonary sarcoidosis. Thorax (1999) 1.02
The complete cDNA sequence and expression of the first major allergenic protein of Malassezia furfur, Mal f 1. Eur J Biochem (1997) 1.01
Ultrastructural liver pathology in patients with minimal liver disease and alpha 1-antitrypsin deficiency: a comparison between heterozygous and homozygous patients. Hepatology (1984) 1.01
Increased numbers of T cells recognizing multiple myelin basic protein epitopes in multiple sclerosis. Eur J Immunol (1992) 1.01
Multiple epitopes on cartilage type II collagen are accessible for antibody binding in vivo. Autoimmunity (1991) 1.01
Ketoconazole in atopic dermatitis: therapeutic response is correlated with decrease in serum IgE. Arch Dermatol Res (1995) 1.01
Iron increases ethanol toxicity in rat liver. J Hepatol (1993) 1.00
X-linked agammaglobulinemia and other immunoglobulin deficiencies. Immunol Rev (1994) 1.00